|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/17 | (2006.01) |
| A61K 47/00 | (2006.01) |
| (11) | Number of the document | 2586459 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13152402.7 |
| Date of filing the European patent application | 2006-03-22 | |
| (97) | Date of publication of the European application | 2013-05-01 |
| (45) | Date of publication and mention of the grant of the patent | 2017-05-24 |
| (46) | Date of publication of the claims translation | 2017-09-25 |
| (30) | Number | Date | Country code |
| 665125 P | 2005-03-25 | US |
| (72) |
DIX, Daniel, US
FRYE, Kelly, US
KAUTZ, Susan, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | VEGF antagonisto kompozicijos |
| VEGF ANTAGONIST FORMULATIONS |
| Payment date | Validity (years) | Amount | |
| 2025-02-18 | 20 | 347.00 EUR |